×

BIOMARKERS FOR RESPONSE TO TYROSINE KINASE PATHWAY INHIBITORS IN CANCER

  • US 20130230511A1
  • Filed: 02/04/2013
  • Published: 09/05/2013
  • Est. Priority Date: 02/03/2012
  • Status: Abandoned Application
First Claim
Patent Images

1. A method of treating a cancer patient comprising:

  • (a) selecting a patient determined to have a cancer with an elevated KDR, PDGFR, or KIT level; and

    (b) treating the patient with a VEGF/VEGFR, PDGFR, or KIT pathway inhibitor.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×